CAS 1338934-59-0

Formel: C18H19NO7

InChl: InChI=1S/C18H19NO7/c1-10-11-7-14(24-2)16(22)13(9-20)17(11)26-18(23)12(10)8-15(21)19-3-5-25-6-4-19/h7,9,22H,3-6,8H2,1-2H3

InChI Key: IFDGMRMUJYGWQQ-UHFFFAOYSA-N

SMILES: CC1=C(C(=O)OC2=C(C(=C(C=C12)OC)O)C=O)CC(=O)N3CCOCC3

MKC8866

CAS: 1338934-59-0

MKC8866, a selective IRE1 RNase inhibitor with an IC50 of 0.29 μM, curbs breast and prostate cancer cell growth.

Formel: C₁₈H₁₉NO₇

Reinheit: 99.28% - 99.91%

Farbe und Form: Yellow Solid

Molekulargewicht: 361.35

Ref: TM-T15594

MKC8866

CAS: 1338934-59-0

MKC8866

Formel: C₁₈H₁₉NO₇

Reinheit: 99.5%

Molekulargewicht: 361.35

Ref: 54-BUP12551

2H-1-Benzopyran-8-carboxaldehyde, 7-hydroxy-6-methoxy-4-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-2-oxo-

CAS: 1338934-59-0

Formel: C₁₈H₁₉NO₇

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 361.3460

Ref: IN-DA01EOOW

7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde

CAS: 1338934-59-0

7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde

Formel: C₁₈H₁₉NO₇

Reinheit: 99%

Molekulargewicht: 361.35

Ref: IN-DG00961093

MKC8866

CAS: 1338934-59-0

MKC8866 is a selective antagonist that targets the metabotropic glutamate receptor 2 (mGluR2), which is a type of glutamate receptor expressed in various regions of the central nervous system (CNS). Derived from pharmacological research, this compound offers critical insights into the modulation of synaptic activity and neuronal signaling through inhibition of mGluR2.

Formel: C₁₈H₁₉NO₇

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 361.35 g/mol

Ref: 3D-NDC93459